NCT02068196View on ClinicalTrials.gov

A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Malignant Melanoma
Interventions
PROCEDURE

Blood sampling for Pre-existing immunity

Identify predictive biomarkers of long term study survivors who have substantially benefited from ipilimumab therapy

DRUG

Ipilimumab

Trial Locations (8)

Unknown

Ålesund Hospital, Ålesund

Haukeland University Hospital, Bergen

Nordland Hospital Bodø, Bodø

Sørlandet Hospital, Kristiansand, Kristiansand

Oslo University Hospital, Oslo

Stavanger University Hospital, Stavanger

University Hospital of North Norway, Tromsø

Trondheim University Hospital, St.Olavs Hospital, Trondheim

All Listed Sponsors
lead

Oslo University Hospital

OTHER